메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

SITE MAP

Quratis

Tel : +82 2 866 0604   Fax : +82 2 867 0125   Email : info@quratis.com

CONTACT US

  • Global Innovation
    Leader

    Innovative leader across borders
    Making people happy

  • Core
    Technology

    Adjuvant Platform &
    Cell Therapy Platform Technology

  • CDMO
    Business

    Development of Process/ Analytics/ Formulation,
    DS/DP of Biological Products, etc.

01

Scroll

Quratis
Business

Quratis
 Business area

  • 01

    TB vaccine (QTP101)

    Our body's immune system will be activated,
    and our body will be able to cope with the
    pathogens that will invade in the future.

    VIEW MORE
  • 02

    COVID-19 vaccine (QTP104)

    A substance used with an antigen
    to enhance cellular and fluid
    immune response to a particular antigen.

    VIEW MORE
  • 03

    CPP Platform

    Numerous trials, Secured original technology for cell/bacterial
    penetrating peptide drug delivery platform,
    Applicable to all antibiotics, antiviral and anticancer drugs.

    VIEW MORE

Quratis
BusinessⅡ

Quratis
 Business area

  • 04

    Peptide Nucleic Acid (PNA)

    PNA is a synthetic analogue of DNA in which
    the deoxyribose phosphate
    backbone is replaced by a polyamide chain.

    VIEW MORE
  • 05

    CMO&CDMO

    Custom services such as development of
    biopharmaceutical raw materials and finished
    pharmaceutical manufacturing processes

    VIEW MORE
  • 06

    ETC

    VIEW MORE

  • Quratis
    R&D

    Quratis is developing
    Innovative vaccines with
    IDRI for global healthcare.

  • Quratis
    R&D

    Quratis is developing
    Innovative vaccines with
    IDRI for global healthcare.

  • Quratis
    R&D

    Quratis is developing
    Innovative vaccines with
    IDRI for global healthcare.